Kira Sheinerman - 20 Jul 2026 Form 3 Insider Report for Niki BioSolutions, Inc. (NIKI)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: NIKI
Reported as of: 20 Jul 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 24 Jul 2026, 16:30:29 UTC
Source filing: View source filing
Reporting owner signature: /s/ Kira S. Sheinerman

Key filing fact

Kira Sheinerman filed Form 3 for Niki BioSolutions, Inc. (NIKI) on 24 Jul 2026.

Key facts

This page summarizes Kira Sheinerman's Form 3 filing for Niki BioSolutions, Inc. (NIKI).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 24 Jul 2026, 16:30.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001438091 Primary reporting owner

Sheinerman Kira

Relationship: Director, 10%+ Owner
Address: C/O NIKI BIOSOLUTIONS, INC., 116 VILLAGE BOULEVARD, SUITE 200, PRINCETON
Signature: /s/ Kira S. Sheinerman
Signature date: 24 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NIKI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,515,293
Date: 20 Jul 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

1,515,016 shares are held directly by the Reporting Person and 277 shares are held in a joint brokerage account, over which the Reporting Person may be deemed to share voting and dispositive power.